News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OncoMed Pharmaceuticals, Inc. Promotes Dr. Jakob Dupont to Chief Medical Officer


1/9/2012 6:51:44 AM

REDWOOD CITY, Calif.--(BUSINESS WIRE)--OncoMed Pharmaceuticals, Inc., a privately held, clinical-stage company developing novel therapeutics that target cancer stem cells, today announced the promotion of Jakob Dupont, M.D., formerly Vice President, Clinical Research, to Senior Vice President and Chief Medical Officer. Dr. Dupont joined OncoMed in October from Genentech, a member of the Roche Group, where he had been Global Medical Director for Avastin® (bevacizumab). Dr. Dupont now heads OncoMed’s global development team and is responsible for advancing multiple novel anti-cancer stem cell therapeutics through all phases of clinical development.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES